AAAAAA

   
Results: 1-11 |
Results: 11
Safety reporting in clinical trials
Authors: Calis, KA Daniels, CE
Citation: Ka. Calis et Ce. Daniels, Safety reporting in clinical trials, J AM MED A, 285(16), 2001, pp. 2076-2076
Use of a parenteral propylene glycol-containing etomidate preparation for the long-term management of ectopic Cushing's syndrome
Authors: Krakoff, J Koch, CA Calis, KA Alexander, RH Nieman, LK
Citation: J. Krakoff et al., Use of a parenteral propylene glycol-containing etomidate preparation for the long-term management of ectopic Cushing's syndrome, J CLIN END, 86(9), 2001, pp. 4104-4108
Hydrocortisone suspension and hydrocortisone tablets are not bioequivalentin the treatment of children with congenital adrenal hyperplasia
Authors: Merke, DP Cho, D Calis, KA Keil, MF Chrousos, GP
Citation: Dp. Merke et al., Hydrocortisone suspension and hydrocortisone tablets are not bioequivalentin the treatment of children with congenital adrenal hyperplasia, J CLIN END, 86(1), 2001, pp. 441-445
Alteplase as an alternative to urokinase
Authors: Semba, CP Bakal, CW Calis, KA Grubbs, GE Hunter, DW Matalon, TAS Murphy, TP Stump, DC Thomas, S Warner, DL
Citation: Cp. Semba et al., Alteplase as an alternative to urokinase, J VAS INT R, 11(3), 2000, pp. 279-287
Thrombolytic therapy with use of alteplase (rt-PA) in peripheral arterial occlusive disease: Review of the clinical literature
Authors: Semba, CP Murphy, TP Bakal, CW Calis, KA Matalon, TAS
Citation: Cp. Semba et al., Thrombolytic therapy with use of alteplase (rt-PA) in peripheral arterial occlusive disease: Review of the clinical literature, J VAS INT R, 11(2), 2000, pp. 149-161
Quality of pharmacotherapy consultations provided by drug information centers in the United States
Authors: Calis, KA Anderson, DW Auth, DA Mays, DA Turcasso, NM Meyer, CC Young, LR
Citation: Ka. Calis et al., Quality of pharmacotherapy consultations provided by drug information centers in the United States, PHARMACOTHE, 20(7), 2000, pp. 830-836
Orlistat, a new lipase inhibitor for the management of obesity
Authors: Heck, AM Yanovski, JA Calis, KA
Citation: Am. Heck et al., Orlistat, a new lipase inhibitor for the management of obesity, PHARMACOTHE, 20(3), 2000, pp. 270-279
Olanzapine pharmacokinetics in pediatric and adolescent inpatients with childhood-onset schizophrenia
Authors: Grothe, DR Calis, KA Jacobsen, L Kumra, S DeVane, CL Rapoport, JL Bergstrom, RF Kurtz, DL
Citation: Dr. Grothe et al., Olanzapine pharmacokinetics in pediatric and adolescent inpatients with childhood-onset schizophrenia, J CL PSYCH, 20(2), 2000, pp. 220-225
Bosentan and the endothelin system in congestive heart failure
Authors: Ellahham, SH Charlon, V Abassi, Z Calis, KA Choucair, WK
Citation: Sh. Ellahham et al., Bosentan and the endothelin system in congestive heart failure, CLIN CARD, 23(11), 2000, pp. 803-807
Bioactivity of cryopreserved alteplase solutions
Authors: Calis, KA Cullinane, AM Horne, MK
Citation: Ka. Calis et al., Bioactivity of cryopreserved alteplase solutions, AM J HEAL S, 56(20), 1999, pp. 2056-2057
Thrombocytopenia after isolated limb or hepatic perfusions with melphalan;The risk of heparin-induced thrombocytopenia
Authors: Masucci, IP Calis, KA Bartlett, DL Alexander, HR Horne, MK
Citation: Ip. Masucci et al., Thrombocytopenia after isolated limb or hepatic perfusions with melphalan;The risk of heparin-induced thrombocytopenia, ANN SURG O, 6(5), 1999, pp. 476-480
Risultati: 1-11 |